Riskpilot← Back to searchSign inGet full accessSURVIVA AS
ASActiveOrg 998297478Kalvskinnet 11, 6460 Eidsvåg I RomsdalResearch and experimental development on natural sciences and engineering · NACE 7210Est. 20125 employeeswww.surviva.no
Revenue 2024
NOK 4,8M
+35% vs 2023
EBITDA margin
13.1%
+194% vs 2023
Equity ratio
44.6%
Financial strength
Net profit 2024
NOK 8K
+101% vs 2023
| Revenue | NOK 4,8M | +35% |
| EBITDA | NOK 632K | +194% |
| Net profit | NOK 8K | +101% |
| Total assets | NOK 6,4M | -8% |
| Equity | NOK 2,8M | +0% |
| Employees | 5 | — |
Legal name
SURVIVA AS
Org number
998297478
Legal form
Aksjeselskap
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
7. mai 2012
Share capital
NOK 116 000
Employees
5 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Daglig leder alene.
Company purpose
Drive kunnskapsbasert konsulentvirksomhet innen helse og livsvitenskap samt aktivitet som hører naturlig til dette, herunder å delta i andre selskaper med lignende virksomhet og kjøp og salg av aksjer.
Address
Kalvskinnet 11, 6460 Eidsvåg I Romsdal
Website
www.surviva.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 972 | 5 540 | 8 798 | 3 562 | 4 807 |
| Staff expenses | −271 | −2 946 | −4 543 | −2 977 | −2 490 |
| EBITDA | 456 | 1 647 | 2 474 | −673 | 632 |
| Depreciation & amort. | −49 | −61 | −146 | −349 | −342 |
| EBIT | 407 | 1 586 | 2 328 | −1 023 | 290 |
| Net financials | 98 | −804 | −14 | −134 | −305 |
| Profit before tax | 505 | 782 | 2 314 | −1 156 | −15 |
| Tax | 81 | 343 | 510 | −338 | −24 |
| Net profit | 423 | 439 | 1 804 | −818 | 8 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 867 | 3 196 | 4 981 | 6 912 | 6 351 |
| Equity | 856 | 1 163 | 2 575 | 2 823 | 2 831 |
| Long-term debt | 664 | 564 | 472 | 2 183 | 2 027 |
| Short-term debt | 347 | 1 469 | 1 933 | 1 906 | 1 494 |
| Total debt | 1 011 | 2 033 | 2 406 | 4 089 | 3 521 |
EBITDA margin
13.1%
This company
15.8%
Market median
-17% vs market
20202024
Equity ratio
44.6%
This company
38.2%
Market median
+17% vs market
20202024
Return on equity
0.3%
This company
18.4%
Market median
-98% vs market
20202024
Net profit margin
0.2%
This company
8.1%
Market median
-98% vs market
20202024
Asset turnover
0.76×
This company
1.12×
Market median
-32% vs market
20202024
Debt / equity
1.24×
This company
0.62×
Market median
-100% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 11.98% | 11.98% | 2024 | |
| Individual | 3% | 3% | 2022 | |
| Company | 2.78% | 2.78% | 2024 | |
| Individual | 2.34% | 2.34% | 2024 | |
| Individual | 2.3% | 2.3% | 2022 | |
| Individual | 2.01% | 2.01% | 2024 | |
| Individual | 1.8% | 1.8% | 2024 | |
| Individual | 1.8% | 1.8% | 2024 | |
| Individual | 1.56% | 1.56% | 2024 | |
| Individual | 1.5% | 1.5% | 2022 | |
| Individual | 1.17% | 1.17% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
SURVIVA AS 
POSTR ASBoard members of SURVIVA AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Astrid Hilde Myrset | Chairman | 0 companies |